comprehensive -WSS

comprehensive

author：hotspot 2025-10-03 00:38:57 - browse：75784

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Why we need mandatory labeling of GMO products

hotspot

WSS

Plastic surgeons increase patient psychiatric screenings

Decentralized clinical trials need collaboration to achieve wider use

Nurses recount patients attacks

Nurses recount patients attacks

Nurses recount patients attacks

Should insurance cover cosmetic surgery?

focus

comprehensive

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Colonoscopy prep: Liquid

ChatGPT in medicine: STAT answers readers' burning questions

Guardant Health colon cancer test endorsed by FDA advisory panel

How one medical school became remarkably diverse

Beyond aggravation: Constipation is an American epidemic

Tori Bowie and the unacceptable rates of Black maternal death

SCOTUS questions limit to govt efforts to fight misinformation

focus

Louisiana bill approved classifying abortion pills as controlled substances

The Bio Revolution is changing business and society

SCOTUS questions limit to govt efforts to fight misinformation

Virtual Event: March of the Biosimilars

Health AI adoption puts security, privacy startups on investors' radar

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

explore

hotspot

focus

explore